Want to see HBIO full AI Analyst Report?
Harvard Bioscience (HBIO) Income Statement
Harvard Bioscience Income Statement
Last quarter (Q2 2026), Harvard Bioscience's total revenue was $22.73M, an increase of 11.13% from the same quarter last year. In Q2, Harvard Bioscience's net income was $-2.91M. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 86.55M | $ 94.14M | $ 112.25M | $ 113.33M | $ 118.90M | |
| $ 45.88M | $ 54.77M | $ 66.07M | $ 60.82M | $ 67.65M | |
| $ 46.51M | $ 60.98M | $ 64.18M | $ 67.75M | $ 65.59M | |
| Depreciation and Amortization | $ 5.95M | $ 7.16M | $ 7.00M | $ 7.58M | $ 7.62M |
| $ -46.52M | $ -1.30M | $ 8.03M | $ 944.00K | $ 9.02M | |
| $ -629.00K | $ -6.21M | $ 1.89M | $ -6.93M | $ 2.07M | |
| $ -56.76M | $ -5.45M | $ -4.45M | $ -2.25M | $ -2.21M | |
| $ -57.39M | $ -11.66M | $ -2.56M | $ -9.18M | $ -140.00K | |
| $ -56.70M | $ -12.40M | $ -3.42M | $ -9.52M | $ -288.00K | |
| Per Share Metrics | |||||
| Basic EPS | $ -12.80 | $ -2.80 | $ -0.81 | $ -2.30 | $ -0.07 |
| Diluted EPS | $ -12.80 | $ -2.80 | $ -0.81 | $ -2.30 | $ -0.07 |
| Weighted Average Shares Outstanding | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M |
| Weighted Average Shares Outstanding (Diluted) | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M |
Currency in USD
